In a nutshell This study compared real-time continuous glucose monitoring (CGM) to flash CGM for patients with type 1 diabetes (T1D). It found that real-time CGM led to better glucose control and less hypoglycemia, both during daily activity and exercise. Some background Patients with T1D are unable to create the hormone insulin to regulate blood...
Read MoreWhich methods of monitoring blood glucose and administering insulin are better for patients with type 1 diabetes?
In a nutshell This study compared two methods of monitoring blood glucose and administering insulin to see which was most effective for patients with type 1 diabetes (T1D). The authors found that a continuous glucose monitor paired with an insulin pump was more effective at controlling blood glucose levels. Some background Patients with T1D...
Read MoreDo different meals affect glucose levels in people using an artificial pancreas?
In a nutshell This study examined the effects of adding protein and/or fat to a meal with a standard amount of carbohydrates, in adults with type 1 diabetes (T1D) using an artificial pancreas (AP). It was determined adding protein and/or fat did not affect glucose levels over time, but did influence the timing of spikes in glucose levels, and...
Read MoreCan the artificial pancreas improve control of glucose levels without increasing insulin doses?
In a nutshell This study investigated the effectiveness and safety of the artificial pancreas (APs) in people with type 1 diabetes (T1D). It was determined that APs improve control of glucose levels, without increasing the insulin dose. Some background A traditional insulin pump is a small device that continuously delivers insulin, without...
Read MoreImplantable continuous glucose sensor found to be accurate
In a nutshell This study investigated the safety and accuracy of a new implantable continuous glucose monitoring (CGM) sensor. It found that the device was accurate and safe. Some background CGM systems provide real-time information on glucose levels and reduce the need for fingerstick testing. In CGM systems glucose is measured by a sensor placed...
Read MoreArtificial pancreas effective in regulating glucose in patients with well-controlled type 1 diabetes
In a nutshell This study compared a new method of insulin delivery, a hybrid closed-loop system, with standard insulin pumps in patients with type 1 diabetes (T1D). It was found that the time spent at the desired glucose concentration was improved with the closed-loop system. Some background A traditional insulin pump is a small device that...
Read MoreAn artificial pancreas for glucose control
In a nutshell This study examined the safety of an artificial pancreas system. The current study concluded that the artificial pancreas system is safe and also provides better blood sugar control than insulin pump therapy. Some background Achieving normal blood sugar levels can be challenging for patients. An artificial pancreas system has been...
Read MoreCan luseogliflozin enhance control of blood glucose levels in type 2 diabetics?
In a nutshell This study examined the effects of luseogliflozin on blood glucose levels over a 24-hour period. Some background Luseogliflozin (Lusefi) is new treatment for type 2 diabetes (T2D) that prevents glucose (sugar) from being reabsorbed back into the blood from the urine and, therefore, reduces blood glucose levels....
Read MoreThe benefits of using a continuous glucose monitor
In a nutshell This study examined the frequency of continuous glucose monitoring use, the reasons for its use and its effectiveness. Some background Real-time continuous glucose monitoring (CGM) is a device worn by patients allowing them to view their blood glucose (sugar) levels in real-time (every few minutes). This device receives information...
Read MoreWhat is the most convenient glucose monitoring system for type 2 diabetics?
In a nutshell This study compared two blood glucose (sugar) monitoring methods, real-time continuous glucose monitoring and internet-based glucose monitoring, in patients with type 2 diabetes. Some background Patients with diabetes need to monitor their blood glucose levels carefully. Many patient perform self-monitoring, using a glucose monitor....
Read MoreComparing the effects of vildagliptin and glimepiride on glucose fluctuations in patients with type 2 diabetes mellitus.
In a nutshell This study compared the effects of vildagliptin (Zomelis) and glimepiride (Amaryl) on the rise and fall of blood glucose levels (glucose fluctuations) in patients with type 2 diabetes mellitus (T2DM). Some background Patients with T2DM do not produce enough insulin (or are resistant to insulin) necessary to properly use the...
Read MoreMethods of blood glucose measurement and insulin delivery for diabetes
The aim of this review was to determine how the way of administrating insulin and monitoring glucose affects the development of type 1 and 2 diabetes mellitus. All patients with type 1 diabetes (T1DM), and many patients with type 2 diabetes (T2DM) require daily insulin therapy. Monitoring blood glucose levels is a critical part of insulin therapy. The...
Read More